Lessee, Operating Lease, Liability, to be Paid, Year One of Lexaria Bioscience Corp. from 31 Aug 2020 to 30 Nov 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Lexaria Bioscience Corp. quarterly Lessee, Operating Lease, Liability, to be Paid, Year One in USD history and change rate from 31 Aug 2020 to 30 Nov 2025.
  • Lexaria Bioscience Corp. Lessee, Operating Lease, Liability, to be Paid, Year One for the quarter ending 30 Nov 2025 was $28,009.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Year One, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year One, YoY Quarterly Change (%)

Lexaria Bioscience Corp. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year One (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $28,009 +$28,009 30 Nov 2025 10-Q 13 Jan 2026 2026 Q1
Q3 2025 $38,642 +$38,642 31 Aug 2025 10-K 28 Nov 2025 2025 FY
Q2 2025 $37,345 +$28,386 +317% 31 May 2025 10-Q 14 Jul 2025 2025 Q3
Q1 2025 $37,345 +$19,427 +108% 28 Feb 2025 10-Q 14 Apr 2025 2025 Q2
Q4 2024 $0 -$26,878 -100% 30 Nov 2024 10-Q 10 Jan 2025 2025 Q1
Q3 2024 $0 -$35,840 -100% 31 Aug 2024 10-K 26 Nov 2024 2024 FY
Q2 2024 $8,959 31 May 2024 10-Q 12 Jul 2024 2024 Q3
Q1 2024 $17,918 -$17,922 -50% 29 Feb 2024 10-Q 09 Apr 2024 2024 Q2
Q4 2023 $26,878 -$6,733 -20% 30 Nov 2023 10-Q 12 Jan 2024 2023 Q1
Q3 2023 $35,840 31 Aug 2023 10-K 20 Nov 2023 2023 FY
Q1 2023 $35,840 31 Mar 2023 10-Q 14 Jul 2023 2023 Q3
Q4 2022 $33,611 30 Nov 2022 10-Q/A 18 Jan 2023 2023 Q1
Q2 2022 $44,815 +$33,828 +308% 31 May 2022 10-K 28 Nov 2022 2022 FY
Q2 2021 $10,987 31 May 2021 10-Q 15 Jul 2021 2021 Q3
Q1 2021 $21,975 28 Feb 2021 10-Q 14 Apr 2021 2021 Q2
Q4 2020 $32,746 30 Nov 2020 10-Q 14 Jan 2021 2021 Q1
Q3 2020 $43,950 31 Aug 2020 10-K 15 Oct 2020 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.